IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 10

Issue Published : 115

Article Submitted : 19455

Article Published : 8041

Total Authors : 21252

Total Reviewer : 769

Total Countries : 144

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Different estimation method of Ticagrelor
Authors Name: Ashish Kalyankar , Dr. Uday Deokate
Download E-Certificate: Download
Author Reg. ID:
IJRTI_181986
Published Paper Id: IJRTI2205134
Published In: Volume 7 Issue 5, May-2022
DOI:
Abstract: Ticagelor is a drug that prevents platelets from clumping together. It is used to prevent strokes, heart attacks, and other occurrences in persons who have acute coronary syndrome, which is a condition in which blood supply to the heart is disrupted. coronary arteries are the blood vessels in the heart. It works as a platelet aggregation inhibitor by inhibiting blood clotting. Blocking the P2Y 12 receptor It has a half-life of up to 12 hours. Hepatic metabolism and biliary excretion are two types of metabolism. review gives the information about different method of estimation of Ticagelor. That includes the review on pharmaceutical analytical techniques like High-performance liquid chromatography, Reverse phase - High-performance liquid chromatography, Bio-analytical techniques, Spectrometry with the impurities, pharmaceutical dosage forms, bulk, and its formulations used for determination and validation. This review helps us to get updated information on validation of drug-Ticagelor till current date.
Keywords: Ticagelor, HPLC, U. V, validate, impurities
Cite Article: "Different estimation method of Ticagrelor", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.7, Issue 5, page no.812 - 818, May-2022, Available :http://www.ijrti.org/papers/IJRTI2205134.pdf
Downloads: 000205264
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2205134
Registration ID:181986
Published In: Volume 7 Issue 5, May-2022
DOI (Digital Object Identifier):
Page No: 812 - 818
Country: Aurangabad, Maharashtra, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2205134
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2205134
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300

IJRTI

WhatsApp
Click Here

Indexing Partner